Artios
Drug DiscoveryWebsite
Developer of novel cancer treatments designed to target the deoxyribonucleic acid (DNA) damage response. The company's treatments focus on developing therapies through deoxyribonucleic acid damage res...
Valuation
$0
Share Price
N/A
Total Raised
$385.1M
Last Round
Later Stage VC (Series D)
Nov 2025
Latest Funding Round
Later Stage VC (Series D)
Nov 17, 2025
$114.4M
raised
Investors
+27 other investors